Invesco Ltd. - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 230 filers reported holding CONMED CORP in Q1 2023. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$39,651,700
-18.4%
393,175
+10.0%
0.01%
-15.4%
Q2 2023$48,575,511
+27.2%
357,462
-2.8%
0.01%
+18.2%
Q1 2023$38,176,029
+17.2%
367,572
+0.1%
0.01%
+10.0%
Q4 2022$32,559,866
-49.6%
367,327
-54.4%
0.01%
-52.4%
Q3 2022$64,644,000
-16.6%
806,336
-0.3%
0.02%
-8.7%
Q2 2022$77,466,000
-21.3%
808,969
+22.0%
0.02%
-8.0%
Q1 2022$98,474,000
-26.9%
662,906
-30.3%
0.02%
-21.9%
Q4 2021$134,749,000
+14.2%
950,542
+5.4%
0.03%
+6.7%
Q3 2021$118,037,000
-6.5%
902,218
-1.8%
0.03%
-3.2%
Q2 2021$126,278,000
+5.2%
918,857
-0.1%
0.03%
-3.1%
Q1 2021$120,074,000
+15.2%
919,465
-1.2%
0.03%
+6.7%
Q4 2020$104,190,000
+40.2%
930,262
-1.5%
0.03%
+20.0%
Q3 2020$74,329,000
+4.8%
944,811
-4.1%
0.02%0.0%
Q2 2020$70,901,000
+256.0%
984,866
+183.2%
0.02%
+212.5%
Q1 2020$19,915,000
-50.6%
347,735
-3.5%
0.01%
-38.5%
Q4 2019$40,296,000
+4.1%
360,330
-10.5%
0.01%
+30.0%
Q3 2019$38,726,000
+13.6%
402,768
+1.1%
0.01%
+11.1%
Q2 2019$34,101,000
-13.4%
398,510
-15.8%
0.01%
-30.8%
Q1 2019$39,358,000
+25.1%
473,162
-3.4%
0.01%
+8.3%
Q4 2018$31,456,000
-24.5%
489,975
-6.9%
0.01%
-7.7%
Q3 2018$41,678,000
+55.3%
526,110
+43.5%
0.01%
+44.4%
Q2 2018$26,840,000
+42.5%
366,669
+23.3%
0.01%
+28.6%
Q1 2018$18,834,000
+22.6%
297,397
-1.3%
0.01%
+16.7%
Q4 2017$15,363,000
+17.0%
301,408
+20.5%
0.01%
+20.0%
Q3 2017$13,128,000
+173.0%
250,202
+165.0%
0.01%
+400.0%
Q2 2017$4,809,000
+22.9%
94,405
+7.1%
0.00%0.0%
Q1 2017$3,914,000
+9.2%
88,127
+8.6%
0.00%0.0%
Q4 2016$3,585,000
+3.7%
81,174
-5.9%
0.00%0.0%
Q3 2016$3,457,000
-15.8%
86,286
+0.3%
0.00%
-50.0%
Q2 2016$4,105,000
+11.2%
86,012
-2.3%
0.00%
+100.0%
Q1 2016$3,690,000
-18.8%
87,993
-14.7%
0.00%
-50.0%
Q4 2015$4,543,000
-15.2%
103,136
-8.1%
0.00%0.0%
Q3 2015$5,357,000
+4.0%
112,224
+27.0%
0.00%0.0%
Q2 2015$5,150,000
+29.7%
88,388
+12.4%
0.00%0.0%
Q1 2015$3,970,000
+18.3%
78,629
+5.3%
0.00%
+100.0%
Q4 2014$3,357,000
+9.3%
74,680
-10.4%
0.00%0.0%
Q3 2014$3,071,000
-25.8%
83,337
-11.1%
0.00%
-50.0%
Q2 2014$4,140,000
-2.1%
93,779
-3.7%
0.00%0.0%
Q1 2014$4,230,000
-4.0%
97,350
-6.1%
0.00%0.0%
Q4 2013$4,406,000
+28.6%
103,669
+2.8%
0.00%
+100.0%
Q3 2013$3,426,000
+32.9%
100,879
+22.3%
0.00%0.0%
Q2 2013$2,577,00082,4710.00%
Other shareholders
CONMED CORP shareholders Q1 2023
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 310,392$34,764,0004.40%
Iron Triangle Partners LP 148,317$16,612,0002.15%
Ranger Investment Management 294,664$33,002,0001.74%
Penn Capital Management Company, LLC 86,810$9,723,0001.23%
EARNEST PARTNERS LLC 1,575,336$176,438,0001.22%
Champlain Investment Partners, LLC 1,692,014$189,506,0001.09%
MOODY ALDRICH PARTNERS LLC 59,005$6,609,0001.07%
Hood River Capital Management LLC 232,412$26,030,0000.86%
OAK RIDGE INVESTMENTS LLC 80,775$9,047,0000.80%
Huber Capital Management LLC 18,620$2,085,0000.68%
View complete list of CONMED CORP shareholders